Semler Scientific (NASDAQ:SMLR) Trading Down 3.1% – What’s Next?

Semler Scientific, Inc. (NASDAQ:SMLR)’s share price dropped 3.1% on Thursday . The stock traded as low as $67.62 and last traded at $69.08. Approximately 60,779 shares traded hands during mid-day trading, a decline of 80% from the average daily volume of 298,413 shares. The stock had previously closed at $71.28.

Semler Scientific Trading Down 9.6 %

The firm’s 50 day simple moving average is $51.29 and its two-hundred day simple moving average is $37.15. The firm has a market cap of $586.32 million, a price-to-earnings ratio of 30.86 and a beta of 1.17.

Semler Scientific (NASDAQ:SMLR) last released its quarterly earnings results on Monday, November 4th. The company reported $0.72 earnings per share for the quarter, beating analysts’ consensus estimates of $0.37 by $0.35. The company had revenue of $13.51 million during the quarter. Semler Scientific had a net margin of 27.00% and a return on equity of 20.31%.

Institutional Trading of Semler Scientific

A number of institutional investors have recently modified their holdings of SMLR. State Street Corp increased its position in shares of Semler Scientific by 0.6% in the third quarter. State Street Corp now owns 118,223 shares of the company’s stock worth $2,784,000 after purchasing an additional 725 shares during the period. Quest Partners LLC grew its stake in Semler Scientific by 48.0% during the third quarter. Quest Partners LLC now owns 2,520 shares of the company’s stock worth $59,000 after buying an additional 817 shares in the last quarter. Newbridge Financial Services Group Inc. acquired a new stake in Semler Scientific during the second quarter worth about $34,000. US Bancorp DE increased its holdings in Semler Scientific by 60.8% in the 3rd quarter. US Bancorp DE now owns 3,064 shares of the company’s stock valued at $72,000 after buying an additional 1,158 shares during the period. Finally, Rhumbline Advisers raised its position in shares of Semler Scientific by 27.1% in the 2nd quarter. Rhumbline Advisers now owns 6,197 shares of the company’s stock valued at $213,000 after buying an additional 1,320 shares in the last quarter. 49.37% of the stock is currently owned by institutional investors.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.